Portfolio company
RebrAIn
France · £3.1m raised
Raised
£3.1m
Latest stage
Seed
Rounds recorded
1
Backed by
1 investor
Sectors
About
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
SourceFunding history · 1
Similar companies
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
BrainKey
The company develops an artificial intelligence platform providing three-dimensional brain scan visualisations and neurological health insights for physicians and patients.
FIND Neuro
This company develops a clinical decision-support platform that uses brain network analysis to help neurosurgeons identify surgical targets for drug-resistant epilepsy patients.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
AiM Medical Robotics
The company develops portable, MRI-compatible robotic systems for neurosurgeons and hospitals to perform precise, real-time image-guided brain interventions, biopsies and therapeutic deliveries.
Brain-to-Computer Interface
This company develops ultrasound-based brain-computer interfaces to treat neurological and psychiatric conditions for patients with unmet medical needs.
ReEmerge, Inc.
ReEmerge develops deep brain stimulation therapy to restore cognitive function for patients with chronic impairments caused by traumatic brain injuries.
